A recent paper published in the BMJ queried the assessment of the ROCKET AF study that the drug Rivaroxaban is effective in reducing Atrial Fibrillation (AF) related stroke. The group who undertook the ROCKET AF study reviewed their data and have now published their finding in the New England Journal of Medicine that Rivaroxaban does not [...]